FDA Orphan Drug Designation for Bexmarilimab

 

Faron Pharmaceuticals Ltd.



 

 Inside Information:  Faron Receives FDA Orphan Drug Designation for Bexmarilimab in Acute Myeloid Leukemia

 


ODD further strengthens bexmarilimab program...

Related Keywords

Massachusetts ,United States ,Finland ,Boston ,Jukka ,Lapland ,Christopher Golden ,Jenniferc Smith Parker ,Juha Karttunen ,Jo Turner ,Sandy Jamieson ,Peel Hunt ,Drug Administration ,Faron Pharmaceuticals Ltd ,Company Announcement ,Head Of Communications ,Cairn Financial Advisers ,Office Of Orphan Drug Products ,Faron Pharmaceuticals ,Faron Receives ,Drug Designation ,Acute Myeloid ,First North ,Orphan Drug Designation ,Orphan Drug Products ,Chief Medical Officer ,Certified Adviser ,Nasdaq First ,Markets ,